Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.33% to 1,814.50 Indian rupees Monday, on what proved to be an all-around positive trading session for the stock market, with the BSE ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sun Pharmaceutical Industries Ltd. 524715 shares rallied 1.28% to 1,823.35 Indian rupees Thursday, on what proved to be an all-around poor trading session for the stock market, with the BSE SENSEX ...

Closing Bell: Market Rally Continue For The 2nd Straight Day, Sensex & Nifty Rise Nearly 2% Each Rally On D-Street: Market Gains For The 2nd Straight Day, Sensex & Nifty Rise Led By Auto Stocks ...

Vidhi Shanghvi, the daughter of Dilip Shanghvi, the founder of Sun Pharmaceutical Industries and an heir to the company's vast healthcare empire, has reportedly garnered significant attention for her ...

According to the Red Herring Prospectus (RHP), Senores Pharmaceuticals is a global research-driven pharmaceutical company focused on the development and manufacture of a diverse range of ...

A NUMBER of linear polyelectrolytes—acid as well as basic—give high dielectric increments in aqueous solution, when compared with less asymmetric proteins and simple dipolar ions.

The cooperation between Pharmaceutical Traders Association and Japan Federation of Medical Devices Associations of the two countries can contribute to stabilize the global supply-chain especially of ...

Here’s how it works. The sun is far from quiet. Yesterday, Dec. 17, the sun fired out an 'extremely rare' farside coronal mass ejection (CME) — a vast plume of plasma and magnetic field.

Vidhi Shanghvi, daughter of Sun Pharma’s Dilip Shanghvi, plays a key role in the ₹4.35 lakh crore healthcare empire.(Photo via X (Twitter)) Vidhi Shanghvi, daughter of Dilip Shanghvi and Sun ...

After three decades of distinguished work in the United States, world-leading cancer researcher Sun Shao-Cong has returned to China to establish a new lab in Beijing, following what a source said ...